How are we doing? Give us your feedback on the new rheumatology.org.

Share Feedbackexternal link opens in a new tab.

ACR Journals on Air Podcast

Logo

Welcome to ACR Journals on Air, the ACR’s newest podcast series featuring interviews, commentary, and analysis on research from our three peer-reviewed journals: Arthritis & Rheumatology, Arthritis Care & Research, and ACR Open Rheumatology. Join us each episode for engaging discussions with authors and independent experts about recently published studies, their implications for clinical care, and how they move the field of rheumatology forward.

Whether it’s an expert analysis of a manuscript or deep dive with an author—our goal is the same—to understand the impact of the science and bring it from the bench to the bedside.

Podcast Host

Victoria Shanmugam

Victoria Shanmugam, MBBS, MRCP, CCD, has clinical expertise caring for patients with autoimmune diseases, vasculitis, and chronic wounds. She has led several research studies investigating scleroderma, hidradenitis suppurativa, and the interplay of the host immune response and the microbiome in chronic wounds. Dr. Shanmugam is a frequently invited speaker at professional meetings. Her work in wound healing, hidradenitis, and scleroderma has been published in high-impact peer-reviewed journals, such as Arthritis Care and Research, Current Opinion in Rheumatology, International Wound Journal, and Clinical Rheumatology. Connect with Dr. Shanmugam on Twitter (@VickiShanmugam).

Episodes

New episodes will be available twice a month on Tuesdays.

Episode 18 – Less Is More

Episode 17 – Location, Location, Location

Episode 16 – SSc Pulmonary Hypertension

Episode 15 – Uric Acid: How Low Can You Go

Episode 14 – RheumMadness

Browse previous episodes in the ACR Journals on Air archive.

Episode Show Notes

Caring for older adults who suffer from rheumatic disease comes with it the need to manage multimorbidity, polypharmacy, and geriatric syndromes. Often, shifting priorities for those suffering with rheumatic musculoskeletal diseases (RMDs) is needed, sometimes leading to a prescribing cascade. The practice of ‘deprescribing’, an approach to optimize medication use to deliver a more ‘goal-concordant’ type of care was the focus of Dr. Una Makris and Dr. Jiha Lee’s latest research, Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More. When caring for older adults with RMDs, it very well may be that less is more.

Una Makris
Una Makris, MD, MSc - Una Makris, MD, MSc, is an Associate Professor of Internal Medicine in the Division of Rheumatic Diseases at UT Southwestern Medical Center and a clinical investigator at the VA North Texas Health Care System. As a clinically trained rheumatologist, with a research focus on aging, she is well positioned to investigate important questions that bridge the fields of rheumatology and geriatrics. Dr. Makris’ research (funded by VA HSR&D, NIA, RRF) focuses on developing innovative behavioral interventions for older adults with comorbid musculoskeletal pain and depression. As a health services researcher, her goal is to ultimately improve outcomes in this medically complex older population by developing safe, effective, and accessible interventions that shift the focus from pharmacological therapies to behavioral (physical activity) interventions.

 

Jiha Lee
Jiha Lee, MD, MS - Jiha Lee, MD, MS, is an Assistant Professor in the Division of Rheumatology in the Department of Internal Medicine at the University of Michigan (U-M) Ann Arbor. She completed her rheumatology fellowship and earned a Master of Health Sciences degree at Yale University. Dr. Lee’s long-term goal is to optimize safe and effective use of disease modifying antirheumatic drug use in older adults with RA. Since joining the faculty at U-M in 2017, she gained additional training in aging-related health services research as a Research Education Core scholar of the U-M Claude D. Pepper Older American Independence Center. Dr. Lee is funded by the National Institute of Aging (NIH/NIA) and is a GEMSSTAR awardee which is intended for specialty trained early career physician scientist to transition to aging research. Her research focuses on understanding suboptimal DMARD use in older adults with new diagnosis of late-onset RA, and for those who achieved disease remission, to evaluate de-escalation of biologics in older adults with RA. For the latter work, she was selected into the US Deprescribing Network Junior Intensive Program and has been collaborating with researchers across multiple disciplines.

Related Links:

Don’t forget to like, share, and subscribe!

Submit Show Feedback

In a study recently published in ACR Open Rheumatology, Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States, first author Sharon Dowell, MD, set out to understand some of the factors associated with regional variation of rheumatoid arthritis (RA) in the United States. Dr. Dowell presents her study’s findings and conclusions. Tracy Johansson, MS, member of the RISE registry team, joins us to discuss how RISE attempts to close these gaps. Together, both of our guests help us to understand how geographic location contributes to a disproportionate level of care for those with RA and what we can do about it.

Sharon Dowell, MD
Sharon Dowell, MD - Sharon Dowell, MD, is a graduate of the University of the West Indies. She completed her internal medicine residency at the University of Connecticut and her Rheumatology Fellowship at the University of Maryland. She is now an Associate Professor of Medicine at Howard University in Washington, DC, fulfilling the tripartite mission of medical education, research, and clinical care.

 

Tracy Johansson, MS
Tracy Johansson, MS - Tracy Johansson, MS, has been a member of the ACR’s RISE registry team since March 2016. She was introduced to the field of rheumatology through her previous work with the Rheumatology Research Foundation. Tracy oversees management of the ACR’s suite of rheumatology quality measures and their implementation in RISE, engagement with current and future RISE practices, and the use of RISE data for research. Tracy is an avid sports fan and enjoys reading (more often, listening to) sci-fi/fantasy books.

Related Links:

Don’t forget to like, share, and subscribe!

Submit Show Feedback

Pulmonary hypertension (PH), being a serious complication of systemic sclerosis (SSc), develops late in the course of SSc and carries with it a poor prognosis. With the median survival of about 3 years, new evidence suggests that early diagnosis and treatment can significantly improve survival. Joining us this week is Christopher P. Denton, PhD, FRCP, senior author of Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis, published in Arthritis & Rheumatology. Dr. Denton’s latest study explores the prediction of short-term risk for PH using serial pulmonary function tests (PFTs).

Christopher P. Denton, PhD, FRCP
Christopher P. Denton, PhD, FRCP - Joshua Baker, MD, MSCE, is an Associate Professor of Rheumatology and Epidemiology at the University of Pennsylvania and at the Corporal Michael J. Crescenz Veterans Affairs Medical Center in Philadelphia. Primarily through the support of VA Awards, Dr. Baker has focused on identifying modifiable risk factors with the goal of improving clinical care of chronic forms of arthritis, particularly rheumatoid arthritis and osteoarthritis. Dr. Baker’s approach includes observational and interventional studies, focusing on skeletal muscle, health, obesity, cardiovascular disease, bone and joint health, and their associated long-term outcomes in patients with common forms of arthritis.

Related Links:

Don’t forget to like, share, and subscribe!

Submit Show Feedback

In this episode, we are joined by Joshua Baker, MD, MSCE, first author of a paper recently published in Arthritis & Rheumatology, Associations Between Low Serum Urate, Body Composition, and Mortality. Dr. Baker, recognizing the controversy in whether low serum urate or uric acid (UA) level contribute to adverse outcomes, set out to evaluate the relation between low serum UA levels and sarcopenia, to assess whether sarcopenia confounds associations between these low levels and mortality.

Joshua Baker, MD, MSCE
Joshua Baker, MD, MSCE - Joshua Baker, MD, MSCE, is an Associate Professor of Rheumatology and Epidemiology at the University of Pennsylvania and at the Corporal Michael J. Crescenz Veterans Affairs Medical Center in Philadelphia. Primarily through the support of VA Awards, Dr. Baker has focused on identifying modifiable risk factors with the goal of improving clinical care of chronic forms of arthritis, particularly rheumatoid arthritis and osteoarthritis. Dr. Baker’s approach includes observational and interventional studies, focusing on skeletal muscle, health, obesity, cardiovascular disease, bone and joint health, and their associated long-term outcomes in patients with common forms of arthritis.

Related Links:

Don’t forget to like, share, and subscribe!

Submit Show Feedback

When rheumatology concepts battle it out in a team bracket tournament, you get RheumMadness—A place for everyone who is crazy about rheumatology to connect, collaborate and compete, in an online learning experience, created by David Leverenz, MD. His body of work, RheumMadness: Creating an Online Community of Inquiry, featured in this episode, analyzes participant engagement and the presence of the online community of inquiry within its first year. Dr. Leverenz is an educator and rheumatologist at Duke University, and has a growing body of work in medical education. He recently completed a Clinician Scholar Educator Award from the Rheumatology Research Foundation to create Rheum Madness.

David Leverenz, MD
David Leverenz, MD - David Leverenz, MD, graduated from UT Southwestern Medical School in Dallas, TX. His residency training was at Vanderbilt University Medical Center in Nashville, TN, where he also served as a chief resident. He completed fellowship training in rheumatology at Duke University, where he is now on faculty as an assistant professor of medicine and the program director of the adult rheumatology fellowship program. Dr. Leverenz's academic interests are in medical education and quality improvement.

Related Links:

Don’t forget to like, share, and subscribe!

Submit Show Feedback

Subscribe & Rate

Subscribe to our podcasts in your favorite podcast listening platform, and they’ll notify you when new episodes are available. Like what you hear? Don’t forget to leave a review!

 

Podcast Feedback

We love to hear from our listeners. Tell us how we are doing.

We use cookies on our website to improve our service to you and for security purposes. By continuing to use our site without changing your browser cookie settings, you agree to our cookie policy and the use of cookies. See ACR Policies